GamaMabs Pharma - Ownership and Business Overview

Life ScienceCompany

GamaMabs Pharma Ownership

Who owns GamaMabs Pharma?

.

GamaMabs Pharma Business Overview

Where is GamaMabs Pharma headquartered?

GamaMabs Pharma is headquartered in Toulouse, France.

What sector is GamaMabs Pharma in?

GamaMabs Pharma is a life science company.

When was GamaMabs Pharma founded?

GamaMabs Pharma was founded in 2013.

Life Science M&A Summary in

Subscribe to Mergr to view all 0 acquisitions of life science companies in , including .

GamaMabs Pharma

GamaMabs Pharma SA

1 Place Pierre Potier,
Toulouse, 31106
France,
+33 (0)5 31 61 60 69
www.gamamabs.com

GamaMabs Pharma is an immuno-oncology biotechnology company, provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer. The company develops low-fucose EMABling® antibodies (license granted by LFB) with increased tumor cell killing properties through a breakthrough activation of immune cells. GamaMabs Pharma was founded in 2013 and is based in Toulouse, France.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - 1 - - - - 1
vol $5M $5M
  1

Most Recent M&A

Company Date Value Type
GamaMabs Pharma - AMHR2 Antibody Technology 2021-05-04 5M USD Divestiture
Toulouse, France
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) 5M (100%)
Total - - 1 $5M

By Geo

State/Country Buy Value Sell Value
France - - 1 5M
Total - - 1 $5M

Deal Values

sell # Total
< $100M 1 $5M
TOTAL $5M
Largest GamaMabs Pharma - AMHR2 Antibody Technology
$5M (2021-05-04)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for GamaMabs Pharma

Life Science Companies